Chinese Network of Pediatric Antiretroviral Therapy (CN-PART)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01210924 |
Recruitment Status
:
Completed
First Posted
: September 29, 2010
Last Update Posted
: March 30, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Acquired Immunodeficiency Syndrome |
Study Type : | Observational |
Actual Enrollment : | 400 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Chinese Study of Pediatric Antiretroviral Therapy |
Study Start Date : | April 2010 |
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | December 2015 |

Group/Cohort |
---|
Pediatric ART patients |
- The immunology and virologic outcomes [ Time Frame: 2016 ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 15 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- clinical diagnosis of HIV infection
- receiving triple antiretroviral drugs
Exclusion Criteria:
- clinical status not stable

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01210924
China | |
National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention | |
Beijing, China, 102206 |
Principal Investigator: | Fujie Zhang, MD | National Center for AIDS/STD control and prevention |
Responsible Party: | National Center for AIDS/STD Control and Prevention, China CDC |
ClinicalTrials.gov Identifier: | NCT01210924 History of Changes |
Other Study ID Numbers: |
Pediatric treatment 2010 2008ZX10001-007 ( Other Grant/Funding Number: Chinese Ministory of Health ) |
First Posted: | September 29, 2010 Key Record Dates |
Last Update Posted: | March 30, 2018 |
Last Verified: | November 2013 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Keywords provided by National Center for AIDS/STD Control and Prevention, China CDC:
children Acquired Immunodeficiency Syndrome antiretroviral therapy China Mortality |
Additional relevant MeSH terms:
Immunologic Deficiency Syndromes Acquired Immunodeficiency Syndrome HIV Infections Immune System Diseases Lentivirus Infections Retroviridae Infections |
RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Slow Virus Diseases |